Alzheimer's Disease: Can We Lower the Risk?

<p>This meta-analysis is a useful reminder of risk factors to look for in your patients. You can also help them understand the long-term risks of Alzheimer's disease.</p> <p>Faculty: Jim Phelps, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC094"> <strong>Learn more about Premium Membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-23-2627?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC094"> <strong>Earn 0.5 CMEs: Quick Take Vol. 23</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/evidence-based-prevention-of-alzheimers-disease-systematic-review-and-meta-analysis-of-243-observational-prospective-studies-and-153-randomised-controlled-trials-2627-4972?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC094"> <strong>Evidence-Based Prevention of Alzheimer's Disease: Systematic Review and Meta-Analysis of 243 Observational Prospective Studies and 153 Randomised Controlled Trials</strong></a></li> </ul>